{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:34:11Z","timestamp":1762353251761,"version":"build-2065373602"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:00:00Z","timestamp":1697328000000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.ejmech.2022.114794","type":"journal-article","created":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T12:51:47Z","timestamp":1664542307000},"page":"114794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter"],"prefix":"10.1016","volume":"244","author":[{"given":"Johnny","family":"Vercouillie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Buron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"S\u00e9rri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuno","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuhal","family":"Gulhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Chartier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle","family":"Chicheri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid","family":"Marzag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeline","family":"Oury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Percina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Bodard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajah","family":"Ben Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Busson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Suzenet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Guilloteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Marchivie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Emond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvain","family":"Routier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1865-8380","authenticated-orcid":false,"given":"Sylvie","family":"Chalon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ejmech.2022.114794_bib1","doi-asserted-by":"crossref","first-page":"e551","DOI":"10.1016\/S2468-2667(20)30190-0","article-title":"The burden of neurological diseases in Europe: an analysis for the global burden of disease study 2017","volume":"5","author":"Deuschl","year":"2020","journal-title":"Lancet Public Health"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114794_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1136\/jnnp-2014-308350","article-title":"Neuronal network disintegration: common pathways linking neurodegenerative diseases","volume":"87","author":"Ahmed","year":"2016","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.ejmech.2022.114794_bib3","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.3390\/cells9122581","article-title":"Novel PET biomarkers to disentangle molecular pathways across age-related neurodegenerative diseases","volume":"9","author":"Wilson","year":"2020","journal-title":"Cells"},{"issue":"8000","key":"10.1016\/j.ejmech.2022.114794_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"2","author":"Davies","year":"1976","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib5","first-page":"437","article-title":"Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease","volume":"19","author":"Whitehouse","year":"1983","journal-title":"Psychopharmacol. Bull."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114794_bib6","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1136\/jnnp.2006.108209","article-title":"Alpha4beta2 nicotinic receptor status in Alzheimer's disease using 123I-5IA-85380 single-photon-emission computed tomography","volume":"78","author":"O'Brien","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"9","key":"10.1016\/j.ejmech.2022.114794_bib8","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2967\/jnumed.109.064030","article-title":"123I-5-IA-85380 SPECT imaging of nicotinic receptors in Alzheimer disease and mild cognitive impairment","volume":"50","author":"Mitsis","year":"2009","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s00259-010-1644-5","article-title":"Decreased cerebral \u03b14\u03b22* nicotinic acetylcholine receptor availability in patients with mild cognitive impairment and Alzheimer's disease assessed with positron emission tomography","volume":"38","author":"Kendziorra","year":"2011","journal-title":"Eur. J. Nucl. Med. Mol. Imag."},{"issue":"Pt 10","key":"10.1016\/j.ejmech.2022.114794_bib10","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/brain\/awt195","article-title":"Magata Y.Alterations in \u03b14\u03b22 nicotinic receptors in cognitive decline in Alzheimer's aetiopathology","volume":"136","author":"Okada","year":"2013","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/ana.20688","article-title":"Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease","volume":"59","author":"Fujita","year":"2006","journal-title":"Ann. Neurol."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114794_bib12","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1038\/jcbfm.2009.74","article-title":"Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease","volume":"29","author":"Kas","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"8","key":"10.1016\/j.ejmech.2022.114794_bib13","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","article-title":"Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease","volume":"66","author":"Meyer","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1212\/WNL.52.4.691","article-title":"In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer's disease","volume":"52","author":"Kuhl","year":"1999","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib15","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1531-8249(199907)46:1<62::AID-ANA10>3.0.CO;2-P","article-title":"Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy","volume":"46","author":"Shinotoh","year":"1999","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.ejmech.2022.114794_bib16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-005-0971-0","article-title":"Cognitive correlates of cortical cholinergic denervation in Parkinson's disease and parkinsonian dementia","volume":"253","author":"Bohnen","year":"2006","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1212\/WNL.0b013e3181ab2b58","article-title":"Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET","volume":"73","author":"Shimada","year":"2009","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/ana.410400309","article-title":"In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease","volume":"40","author":"Kuhl","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2022.114794_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuroimage.2007.11.028","article-title":"In vivo SPECT imaging of vesicular acetylcholine transporter using [(123)I]-IBVM in early Alzheimer's disease","volume":"40","author":"Maz\u00e8re","year":"2008","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2967\/jnumed.116.176180","article-title":"123I-Iodobenzovesamicol SPECT imaging of cholinergic systems in dementia with Lewy bodies","volume":"58","author":"Maz\u00e8re","year":"2017","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/(SICI)1098-2396(199811)30:3<263::AID-SYN4>3.0.CO;2-9","article-title":"[18F]fluoroethoxy-benzovesamicol, a PET radiotracer for the vesicular acetylcholine transporter and cholinergic synapses","volume":"30","author":"Mulholland","year":"1998","journal-title":"Synapse"},{"key":"10.1016\/j.ejmech.2022.114794_bib22","doi-asserted-by":"crossref","first-page":"205045","DOI":"10.1155\/2013\/205045","article-title":"Cholinergic depletion in alzheimer's disease shown by [ (18) F]FEOBV autoradiography","volume":"2013","author":"Parent","year":"2013","journal-title":"Int. J. Mol. Imaging"},{"issue":"11","key":"10.1016\/j.ejmech.2022.114794_bib23","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1038\/mp.2017.183","article-title":"Quantification of brain cholinergic denervation in Alzheimer's disease using PET imaging with [18F]-FEOBV","volume":"22","author":"Aghourian","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.celrep.2018.06.001","article-title":"Alzheimer's disease neuroimaging initiative. Longitudinal alzheimer's degeneration reflects the spatial topography of cholinergic basal forebrain projections","volume":"24","author":"Schmitz","year":"2018","journal-title":"Cell Rep."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib25","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.25430","article-title":"Cholinergic system changes of falls and freezing of gait in Parkinson's disease","volume":"85","author":"Bohnen","year":"2019","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejmech.2022.114794_bib26","article-title":"Cholinergic denervation patterns across cognitive domains in Parkinson's disease","author":"van der Zee","year":"2020","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib27","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41380-018-0130-5","article-title":"Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [ 18 F]-FEOBV","volume":"24","author":"Nejad-Davarani","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib28","first-page":"370","article-title":"Bohnen NI.topography of cholinergic changes in dementia with Lewy bodies and key neural network hubs. J neuropsychiatry clin neurosci","volume":"32","author":"Kanel","year":"2020","journal-title":"Fall"},{"issue":"2","key":"10.1016\/j.ejmech.2022.114794_bib29","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cercor\/6.2.165","article-title":"Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease","volume":"6","author":"Geula","year":"1996","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.ejmech.2022.114794_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0079-6123(08)62112-3","article-title":"The systems-level organization of cholinergic innervation in the human cerebral cortex and its alterations in Alzheimer's disease","volume":"109","author":"Mesulam","year":"1996","journal-title":"Prog. Brain Res."},{"issue":"35","key":"10.1016\/j.ejmech.2022.114794_bib31","doi-asserted-by":"crossref","first-page":"21929","DOI":"10.1016\/S0021-9258(17)31734-9","article-title":"Functional identification of a vesicular acetylcholine transporter and its expression from a \"cholinergic\" gene locus","volume":"269","author":"Erickson","year":"1994","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02736782","article-title":"Human and monkey cholinergic neurons visualized in paraffin-embedded tissues by immunoreactivity for VAChT, the vesicular acetylcholine transporter","volume":"6","author":"Schafer","year":"1995","journal-title":"J. Mol. Neurosci."},{"issue":"18","key":"10.1016\/j.ejmech.2022.114794_bib33","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2174\/0929867323666160418114826","article-title":"Considerations in the development of reversibly binding PET radioligands for brain imaging","volume":"23","author":"Pike","year":"2016","journal-title":"Curr. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmech.2022.114794_bib34","doi-asserted-by":"crossref","first-page":"7659","DOI":"10.1016\/j.bmc.2010.08.028","article-title":"3D QSAR study, synthesis, and in vitro evaluation of (+)-5-FBVM as potential PET radioligand for the vesicular acetylcholine transporter (VAChT)","volume":"18","author":"Kovac","year":"2010","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2022.114794_bib35","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/anie.201805501","article-title":"Chemistry for positron emission tomography: recent advances in 11C-","volume":"58","author":"Deng","year":"2019","journal-title":"18F-, 13N-, and 15O-Labeling Reactions. Angew Chem Int Ed Engl"},{"issue":"30","key":"10.1016\/j.ejmech.2022.114794_bib36","first-page":"7751","article-title":"A general copper-mediated nucleophilic 18F fluorination of arenes","volume":"53","author":"Tredwell","year":"2014","journal-title":"Englera"},{"key":"10.1016\/j.ejmech.2022.114794_bib37","doi-asserted-by":"crossref","first-page":"8998","DOI":"10.1002\/anie.200800222","article-title":"Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography","volume":"47","author":"Miller","year":"2008","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14756366.2018.1501043","article-title":"Design of selective COX-2 inhibitors in the (aza)indazole series. Chemistry, in vitro studies, radiochemistry and evaluations in rats of a [18F] PET tracer","volume":"34","author":"Elie","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2022.114794_bib39","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1021\/jm9017916","article-title":"Synthesis and in vitro biological evaluation of carbonyl group-containing inhibitors of vesicular acetylcholine transporter","volume":"53","author":"Efange","year":"2010","journal-title":"J. Med. Chem."},{"issue":"31","key":"10.1016\/j.ejmech.2022.114794_bib40","first-page":"9896","article-title":"Hypervalent iodine(III)-Catalyzed balz\u2013schiemann fluorination under mild conditions. Angew chem int","volume":"57","author":"Xing","year":"2018","journal-title":"Englera"},{"issue":"Pt 1","key":"10.1016\/j.ejmech.2022.114794_bib41","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1107\/S0021889807059870","article-title":"Determination of absolute structure using Bayesian statistics on Bijvoet differences","volume":"41","author":"Hooft","year":"2008","journal-title":"J. Appl. Crystallogr."},{"issue":"Pt 5","key":"10.1016\/j.ejmech.2022.114794_bib42","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1107\/S0108767399004262","article-title":"Absolute structure and absolute configuration","volume":"55","author":"Flack","year":"1999","journal-title":"Acta Crystallogr. A"},{"issue":"Pt 3","key":"10.1016\/j.ejmech.2022.114794_bib43","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1107\/S2052519213010014","article-title":"Use of intensity quotients and differences in absolute structure refinement","volume":"69","author":"Parsons","year":"2013","journal-title":"Acta Crystallogr B Struct Sci Cryst Eng Mater"},{"key":"10.1016\/j.ejmech.2022.114794_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jlcr.2580330704","article-title":"Synthesis of [18F]fluoroethoxy-benzovesamicol, a radiotracer for cholinergic neurons","volume":"33","author":"Mulholland","year":"1993","journal-title":"J. Label. Compd. Radiopharm."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114794_bib45","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1021\/jm00126a013","article-title":"Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenylpiperidino)cyclohexanol (vesamicol)","volume":"32","author":"Rogers","year":"1989","journal-title":"J. Med. Chem."},{"issue":"17","key":"10.1016\/j.ejmech.2022.114794_bib46","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1021\/jm9507486","article-title":"Vesamicol receptor mapping of brain cholinergic neurons with radioiodine-labeled positional isomers of benzovesamicol","volume":"39","author":"Jung","year":"1996","journal-title":"J. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114794_bib47","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.bmc.2003.12.035","article-title":"Synthesis of novel 4- and 5-substituted benzyl ether derivatives of vesamicol and in vitro evaluation of their binding properties to the vesicular acetylcholine transporter site","volume":"12","author":"Scheunemann","year":"2004","journal-title":"Bioorg. Med. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2022.114794_bib48","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejmech.2022.114794_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.nucmedbio.2009.02.007","article-title":"Positron emission tomography imaging of (2R,3R)-5-[(18)F]fluoroethoxybenzovesamicol in rat and monkey brain: a radioligand for the vesicular acetylcholine transporter","volume":"36","author":"Kilbourn","year":"2009","journal-title":"Nucl. Med. Biol."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neuroimage.2012.04.032","article-title":"Landry st-pierre E, cyr M, kostikov A, schirrmacher E, massarweh G, rosa-neto P. PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV)","volume":"62","author":"Parent","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.ejmech.2022.114794_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2014.09.021","article-title":"Deficit in sustained attention following selective cholinergic lesion of the pedunculopontine tegmental nucleus in rat, as measured with both post-mortem immunocytochemistry and in vivo PET imaging with [1\u2078F]fluoroethoxybenzovesamicol","volume":"278","author":"Cyr","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib52","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1021\/acs.molpharmaceut.9b01129","article-title":"Effect of dopamine D2 receptor antagonists on [18F]-FEOBV binding","volume":"17","author":"Schildt","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2022.114794_bib53","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fnins.2019.01438","article-title":"PET imaging of perceptual learning-induced changes in the aged rodent cholinergic system","volume":"13","author":"Cisneros-Franco","year":"2020","journal-title":"Front. Neurosci."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2967\/jnumed.113.124792","article-title":"In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses","volume":"55","author":"Petrou","year":"2014","journal-title":"J. Nucl. Med."},{"issue":"1","key":"10.1016\/j.ejmech.2022.114794_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.celrep.2018.06.001","article-title":"Alzheimer's disease neuroimaging initiative. Longitudinal alzheimer's degeneration reflects the spatial topography of cholinergic basal forebrain projections","volume":"24","author":"Schmitz","year":"2018","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib56","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41380-018-0130-5","article-title":"Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with [18F]-FEOBV","volume":"24","author":"Nejad-Davarani","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib57","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/ana.25430","article-title":"Cholinergic system changes of falls and freezing of gait in Parkinson's disease","volume":"85","author":"Bohnen","year":"2019","journal-title":"Ann. Neurol."},{"issue":"4","key":"10.1016\/j.ejmech.2022.114794_bib58","first-page":"370","article-title":"Topography of cholinergic changes in dementia with Lewy bodies and key neural network hubs. J neuropsychiatry clin neurosci","volume":"32","author":"Kanel","year":"2020","journal-title":"Fall"},{"key":"10.1016\/j.ejmech.2022.114794_bib59","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.120.248500","article-title":"Striatal acetylcholine-dopamine imbalance in Parkinson's disease: in vivo neuroimaging study with dual-tracer PET and dopaminergic PET-informed correlational tractography","author":"Sanchez-Catasus","year":"2021","journal-title":"J. Nucl. Med."},{"issue":"6","key":"10.1016\/j.ejmech.2022.114794_bib60","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jon.12921","article-title":"Aumont \u00c9, Grothe MJ, Soucy JP, Rosa-Neto P, Bedard MA. FEOBV-PET to quantify cortical cholinergic denervation in AD: relationship to basal forebrain volumetry","volume":"31","author":"Aghourian","year":"2021","journal-title":"J. Neuroimaging"},{"key":"10.1016\/j.ejmech.2022.114794_bib61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.parkreldis.2021.09.018","article-title":"Normal cognition in Parkinson's disease may involve hippocampal cholinergic compensation: an exploratory PET imaging study with [(18)F]-FEOBV","volume":"91","author":"Legault-Denis","year":"2021","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.ejmech.2022.114794_bib62","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ejmech.2015.05.033","article-title":"New systematically modified vesamicol analogs and their affinity and selectivity for the vesicular acetylcholine transporter - a critical examination of the lead structure","volume":"100","author":"Barthel","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0014-2999(90)90260-D","article-title":"Metabolites of haloperidol display preferential activity at sigma receptors compared to dopamine D-2 receptors","volume":"177","author":"Bowen","year":"1990","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.ejmech.2022.114794_bib64","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/00001756-199309150-00006","article-title":"Striatal D2\/acetylcholine interactions: PET studies of the vesamicol receptor","volume":"4","author":"Ingvar","year":"1993","journal-title":"Neuroreport"},{"issue":"7","key":"10.1016\/j.ejmech.2022.114794_bib65","first-page":"1192","article-title":"Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding","volume":"37","author":"Efange","year":"1996","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ejmech.2022.114794_bib66","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/syn.890170307","article-title":"Sigma-1 and sigma-2 sites in rat brain: comparison of regional, ontogenetic, and subcellular patterns","volume":"17","author":"McCann","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.ejmech.2022.114794_bib67","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C"},{"key":"10.1016\/j.ejmech.2022.114794_bib68","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Crystallogr."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006961?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523422006961?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:49:21Z","timestamp":1759330161000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523422006961"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":68,"alternative-id":["S0223523422006961"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114794","relation":{},"ISSN":["0223-5234"],"issn-type":[{"type":"print","value":"0223-5234"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and preclinical evaluation of [18F]FBVM as a new potent PET tracer for vesicular acetylcholine transporter","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2022.114794","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114794"}}